Health
Pfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan – Reuters India
Pfizer Inc and BioNTech SE have agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine in the first half of 2021, the companies said on Friday.
(Reuters) – Pfizer Inc (PFE.N) and BioNTech SE (BNTX.O) have agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine in the first half of 2021, the companies said on Friday.
The companies did not disclose the financial details of the agreement, but said terms were based on the volume of doses and the timing of the delivery.
The United States has signed a similar deal with Pfizer and BioNtech for 100 million doses for nearly $2 billion, which amounts to a $39 p…
-
Noosa News22 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business23 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News21 hours agoAfter Hours Gallery Visits, French Dining and Garden Illuminations: Your Guide to the Ultimate Melbourne Culture Fix
-
General18 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change